Financial news, markets, and business updates
Patients relying on Sanofi's Lantus Solostar insulin pen face challenges due to increased demand and supply shortages, with improvements expected soon.
The FDA deliberates on the regulation of compounded peptides as public health implications come to the forefront, alongside key pharmaceutical advances.
President Trump's nomination of Timothy Westlake for SAMHSA marks a pivotal moment for U.S. mental health and addiction policies.
The White House and HHS gather specialists to establish unified principles for evaluating clinical AI technologies.
Public Citizen petitions the FDA to prohibit direct-to-consumer drug ads, claiming they mislead consumers and prioritize persuasion over education.
As the FDA convenes to discuss peptide accessibility, significant debates arise over safety data and the future of compounding pharmacies.
SpaceX has shifted the launch of Starship Flight 13 to July 23, addressing technical issues following an abort at the previous launch attempt.
Federal health officials continue investigations into a cyclospora outbreak linked to Taylor Farms lettuce, despite a false positive test result.
Fifty years since Viking 1's historic Mars landing, NASA is advancing aerial exploration with plans for future helicopter missions on the Red Planet.
Bristol Myers Squibb is partnering with NVIDIA to enhance drug discovery through a new supercomputer, aiming for deeper insights in oncology and neurodegeneration.
An emergency physician shares a personal tragedy, highlighting the flaws in the U.S. health insurance system regarding mental health treatment.
As wildfires blanket U.S. cities in smoke, the soaring asthma cases reveal significant public health challenges linked to climate patterns.
Proposed Medicare fee schedule changes may incentivize doctors to provide more support for smoking cessation, increasing reimbursements for counseling services.
GSK has ceased its efforts to develop a chronic cough therapy, citing the challenges faced during clinical trials.
Sonothera's ultrasound technology promises treatments for Duchenne muscular dystrophy, but experts remain skeptical amid a lack of clinical data.
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.
MAHA's recent initiatives signal a pivotal shift in the dialogue around mental health care, emphasizing deprescribing while sidelining concrete solutions.
The FTC's settlement with CVS Caremark aims to save Americans up to $8.5 billion on insulin by overhauling price manipulation and rebate practices.
Cyclospora infections are at a record high, with Michigan officials pointing to lettuce as a potential source amid an outbreak across multiple states.
The ex-Akero Therapeutics team has formed Avere Therapeutics, targeting immunology with an oral IL-23 inhibitor from a Chinese source.